Aurobindo receives FDA OK for generic Renagel
Sevelamer hydrochloride tablets are indicated for the control of serum phosphorus in patients with chronic kidney disease on dialysis.
Aurobindo has received the Food and Drug Administration’s blessing for Sevelamer hydrochloride tablets, 400 mg and 800 mg, which is the generic of Genzyme’s Renagel.
Sevelamer hydrochloride tablets are indicated for the control of serum phosphorus in patients with chronic kidney disease on dialysis.
[Read more: Aurobindo gets FDA nod for 3 generics]
Sevelamer hydrochloride tablets have a market value of roughly $36.9 million for the 12 months ending May 2023, per IQVIA.